Search

Your search keyword '"Griggs, Eric P."' showing total 6 results
Start Over Author "Griggs, Eric P." Publication Type News
6 results on '"Griggs, Eric P."'

1. Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19--Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions--VISION Network, September 2022-April 2023

Author

Link-Gelles, Ruth, Weber, Zachary A., Reese, Sarah E., Payne, Amanda B., Gaglani, Manjusha, Adams, Katherine, Kharbanda, Anupam B., Natarajan, Karthik, DeSilva, Malini B., Dascomb, Kristin, Irving, Stephanie A., Klein, Nicola P., Grannis, Shaun J., Ong, Toan C., Embi, Peter J., Dunne, Margaret M., Dickerson, Monica, McEvoy, Charlene, Arndorfer, Julie, Naleway, Allison L., Goddard, Kristin, Dixon, Brian E., Griggs, Eric P., Hansen, John, Valvi, Nimish, Najdowski, Morgan, Timbol, Julius, Rogerson, Colin, Fireman, Bruce, Fadel, William F., Patel, Palak, Ray, Caitlin S., Wiegand, Ryan, Ball, Sarah, and Tenforde, Mark W.

Subjects
Medical research, Medicine, Experimental, Messenger RNA, Emergency medicine, Adults, Vaccines, Health
Abstract

On September 1, 2022, CDC's Advisory Committee on Immunization Practices (ACIP) recommended a single bivalent mRNA COVID-19 booster dose for persons aged [greater than or equal to] 12 years who [...]

Published
2023

2. Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance--VISION Network, 10 States, December 2021-August 2022

Author

Britton, Amadea, Embi, Peter J., Levy, Matthew E., Gaglani, Manjusha, DeSilva, Malini B., Dixon, Brian E., Dascomb, Kristin, Patel, Palak, Schrader, Kristin E., Klein, Nicola P., Ong, Toan C., Natarajan, Karthik, Hartmann, Emily, Kharbanda, Anupam B., Irving, Stephanie A., Dickerson, Monica, Dunne, Margaret M., Raiyani, Chandni, Grannis, Shaun J., Stenehjem, Edward, Zerbo, Ousseny, Rao, Suchitra, Han, Jungmi, Sloan-Aagard, Chantel, Griggs, Eric P., Weber, Zachary A., Murthy, Kempapura, Fadel, William F., Grisel, Nancy, McEvoy, Charlene, Lewis, Ned, Barron, Michelle A., Nanez, Juan, Reese, Sarah E., Mamawala, Mufaddal, Valvi, Nimish R., Arndorfer, Julie, Goddard, Kristin, Yang, Duck- Hye, Fireman, Bruce, Ball, Sarah W., Link-Gelles, Ruth, Naleway, Allison L., and Tenforde, Mark W.

Subjects
Vaccination, Messenger RNA, Adults, Vaccines, Health
Abstract

Persons with moderate-to-severe immunocompromising conditions might have reduced protection after COVID-19 vaccination, compared with persons without immunocompromising conditions (1-3). On August 13, 2021, the Advisory Committee on Immunization Practices (ACIP) [...]

Published
2022

3. Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance--VISION Network, 10 States, August 2021-January 2022

Author

Ferdinands, Jill M., Rao, Suchitra, Dixon, Brian E., Mitchell, Patrick K., DeSilva, Malini B., Irving, Stephanie A., Lewis, Ned, Natarajan, Karthik, Stenehjem, Edward, Grannis, Shaun J., Han, Jungmi, McEvoy, Charlene, Ong, Toan C., Naleway, Allison L., Reese, Sarah E., Embi, Peter J., Dascomb, Kristin, Klein, Nicola P., Griggs, Eric P., Konatham, Deepika, Kharbanda, Anupam B., Yang, Duck-Hye, Fadel, William F., Grisel, Nancy, Goddard, Kristin, Patel, Palak, Liao, I-Chia, Birch, Rebecca, Valvi, Nimish R., Reynolds, Sue, Arndorfer, Julie, Zerbo, Ousseny, Murthy, Monica Dickerson Kempapura, Williams, Jeremiah, Bozio, Catherine H., Blanton, Lenee, Verani, Jennifer R., Schrag, Stephanie J., Dalton, Alexandra F., Wondimu, Mehiret H., Link-Gelles, Ruth, Azziz-Baumgartner, Eduardo, Barron, Michelle A., Gaglani, Manjusha, Thompson, Mark G., and Fireman, Bruce

Subjects
Pfizer Inc., Vaccination, Hospitals -- Emergency service, Messenger RNA, Emergency medicine, Adults, Vaccines, Pharmaceutical industry, Health
Abstract

On February 11, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). CDC recommends that all persons aged [greater than or equal to] 12 [...]

Published
2022

4. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19--Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance--VISION Network, 10 States, August 2021-January 2022

Author

Thompson, Mark G., Natarajan, Karthik, Irving, Stephanie A., Rowley, Elizabeth A., Griggs, Eric P., Gaglani, Manjusha, Klein, Nicola P., Grannis, Shaun J., DeSilva, Malini B., Stenehjem, Edward, Reese, Sarah E., Dickerson, Monica, Naleway, Allison L., Han, Jungmi, Konatham, Deepika, McEvoy, Charlene, Rao, Suchitra, Dixon, Brian E., Dascomb, Kristin, Lewis, Ned, Levy, Matthew E., Patel, Palak, Liao, I-Chia, Kharbanda, Anupam B., Barron, Michelle A., Fadel, William F., Grisel, Nancy, Goddard, Kristin, Yang, Duck-Hye, Wondimu, Mehiret H., Murthy, Kempapura, Valvi, Nimish R., Arndorfer, Julie, Fireman, Bruce, Dunne, Margaret M., Embi, Peter, Azziz-Baumgartner, Eduardo, Zerbo, Ousseny, Bozio, Catherine H., Reynolds, Sue, Ferdinands, Jill, Williams, Jeremiah, Link-Gelles, Ruth, Schrag, Stephanie J., Verani, Jennifer R., Ball, Sarah, and Ong, Toan C.

Subjects
Pfizer Inc., Medical research, Medicine, Experimental, Hospitals -- Emergency service, Messenger RNA, Emergency medicine, Adults, Vaccines, Pharmaceutical industry, Health, University of Colorado, Comirnaty (Vaccine)
Abstract

On January 21, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Estimates of COVID-19 mRNA vaccine effectiveness (VE) have declined in recent months [...]

Published
2022

5. Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults--Nine States, January-September 2021

Author

Embi, Peter J., Levy, Matthew E., Naleway, Allison L., Patel, Palak, Gaglani, Manjusha, Natarajan, Karthik, Dascomb, Kristin, Ong, Toan C., Klein, Nicola P., Liao, I.-Chia, Grannis, Shaun J., Han, Jungmi, Stenehjem, Edward, Dunne, Margaret M., Lewis, Ned, Irving, Stephanie A., Rao, Suchitra, McEvoy, Charlene, Bozio, Catherine H., Murthy, Kempapura, Dixon, Brian E., Grisel, Nancy, Yang, Duck-Hye, Goddard, Kristin, Kharbanda, Anupam B., Reynolds, Sue, Raiyani, Chandni, Fadel, William F., Arndorfer, Julie, Rowley, Elizabeth A., Fireman, Bruce, Ferdinands, Jill, Valvi, Nimish R., Ball, Sarah W., Zerbo, Ousseny, Griggs, Eric P., Mitchell, Patrick K., Porter, Rachael M., Kiduko, Salome A., Blanton, Lenee, Zhuang, Yan, Steffens, Andrea, Reese, Sarah E., Olson, Natalie, Williams, Jeremiah, Dickerson, Monica, McMorrow, Meredith, Schrag, Stephanie J., Verani, Jennifer R., Fry, Alicia M., Azziz-Baumgartner, Eduardo, Barron, Michelle A., Thompson, Mark G., and DeSilva, Malini B.

Subjects
Pfizer Inc., Vaccination, Messenger RNA, Adults, Pharmaceutical industry, Health
Abstract

On November 2, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Immunocompromised persons, defined as those with suppressed humoral or cellular immunity resulting [...]

Published
2021

6. Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity--Nine States, January-September 2021

Author

Bozio, Catherine H., Grannis, Shaun J., Naleway, Allison L., Ong, Toan C., Butterfield, Kristen A., DeSilva, Malini B., Natarajan, Karthik, Yang, Duck-Hye, Rao, Suchitra, Klein, Nicola P., Irving, Stephanie A., Dixon, Brian E., Dascomb, Kristin, Liao, I.-Chia, Reynolds, Sue, McEvoy, Charlene, Han, Jungmi, Reese, Sarah E., Lewis, Ned, Fadel, William F., Grisel, Nancy, Murthy, Kempapura, Ferdinands, Jill, Kharbanda, Anupam B., Mitchell, Patrick K., Goddard, Kristin, Embi, Peter J., Arndorfer, Julie, Raiyani, Chandni, Patel, Palak, Rowley, Elizabeth A., Fireman, Bruce, Valvi, Nimish R., Griggs, Eric P., Levy, Matthew E., Zerbo, Ousseny, Porter, Rachael M., Birch, Rebecca J., Blanton, Lenee, Ball, Sarah W., Steffens, Andrea, Olson, Natalie, Williams, Jeremiah, Dickerson, Monica, McMorrow, Meredith, Schrag, Stephanie J., Verani, Jennifer R., Fry, Alicia M., Azziz-Baumgartner, Eduardo, Barron, Michelle, Gaglani, Manjusha, Thompson, Mark G., and Stenehjem, Edward

Subjects
Pfizer Inc., Vaccination -- Health aspects, Messenger RNA -- Health aspects, Infection -- Health aspects, Adults -- Health aspects, Vaccines -- Health aspects, Pharmaceutical industry -- Health aspects, Health
Abstract

On October 29, 2021 this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Previous infection with SARS-CoV-2 (the virus that causes COVID-19) or COVID-19 vaccination [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results